Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSV-0219 is a positive allosteric modulator (PAM) of the glucagon-like peptide 1 receptor (GLP-1R).1 It is selective for GLP-1R over a panel of 54 other receptors, ion channels, and transporters at 10 µM. V-0219 (0.001-1 nM) potentiates GLP-1-induced cAMP accumulation in HEK293 cells expressing human GLP-1R. It also potentiates GLP-1-induced insulin secretion in INS-1E rat insulinoma cells, an effect that can be blocked by the GLP-1R antagonist exendin (9-39) amide. V-0219 improves glucose tolerance in wild-type, but not Glp1r knockout, mice when administered at a dose of 0.1 mg/kg and enhances a reduction in food intake induced by the GLP-1R agonist exendin-4 in rats at 0.001 mg/kg.
WARNING This product is not for human or veterinary use.
1. Discovery of V-